Phage Safety Retrospective Cohort Study (PHASACO-retro)

Civil Hospices of Lyon

Status: Enrolling

Conditions: Prosthetic Joint Infection; Bone and Joint Infection

Treatments: Other: patients having had avderse event after phagotherapy for bone or joint or implant infection

Study type: Observational

Funder types: Other

Identifiers

NCT04724603

334

Details and patient eligibility

About

The aim of this study is to determine the imputability of adverse events in patients who have had phage therapy for the treatment of their bone or joint or implant infection, in order to find out whether these adverse effects are related to surgery, antibiotic treatment or bacteriophages.

Enrollment: 25 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients having had a bone or joint or implant infection treated by phagotherapy and having had an adverse event

Exclusion criteria

Trial design

25 participants in 1 patient group

patients having had avderse event after phagotherapy for bone or joint infection

Treatment:

Other: patients having had avderse event after phagotherapy for bone or joint or implant infection